BBI Solutions (BBI), Cardiff, UK, has launched Scipac clinical specimen panels, quantitative panels of clinical specimens collected from multiple donors of known genotype. Panels include hepatitis, human immunodeficiency virus, and syphilis. Adding to BBI’s biobank portfolio, the panels can assist research and development and quality control (QC) departments with their QC testing to assess proof of concept experiments when developing new assays for infectious diseases. Materials are undiluted, virally tested, and do not contain preservatives. Samples are collected and manufactured with ethically approved protocols and with the consent of the donor. For more information, visit BBI Solutions.
October 4, 2021